Characterization of differentiation factor/leukaemia inhibitory factor effect of lipoprotein lipase activity and mRNA in 3T3-L1 adipocytes

doi:10.1016/1043-4666(94)90067-1

Cytokine

Volume 6, Issue 4, July 1994, Pages 425-432

https://doi.org/10.1016/1043-4666(94)90067-1 Get rights and content

Abstract

Alterations in lipid metabolism characterized in major part by a decrease in lipoprotein lipase (LPL) activity in adispose tissue are a central feature of cachexia from chronic infection or malignancy. These metabolic derangements may be mediated in large part through endogenous host proteins produced in response to various pathological stimuli. Differentiation factor/leukaemia inhibitory factor (D-factor) is a cytokine whose functions overlap those of tumour necrosis factor-α (TNF), IL-6 and IL-1. Recombinant murine D-factor produced a dose- and time-dependent inhibition of heparin-releasable LPL activity in differentiated 3T3-L1 adipocytes. Although 2–10 fold less potent than recombinant murine TNF, D-factor inhibited LPL activity at concentrations of 1–10 ng/ml. When added together, D-factor and TNF produced a synergistic inhibition of LPL activity. Interleukin 6 (IL-6) was 100-fold less potent than D-factor; 0.1 ng/ml of D-factor or 10 ng/ml of IL-6 caused a 50% inhibition of LPL activity. D-factor and TNF increased IL-6 production in 3T3-L1 cells. Ten ng/ml of D-factor or 1.0 ng/ml of TNF stimulated the release of <1 ng/ml of IL-6 and inhibited LPL activity to 11 ± 3% and 3 ± 2% of control, respectively, whereas 50 ng/ml of recombinant IL-6 was required to decrease LPL activity to 24 ± 19% of control. TNF produced a marked decrease in LPL mRNA, whereas D-factor had minimal or no effect at doses which inhibited LPL activity almost completely. Western blot analysis of cell extracts showed that TNF caused a greater decrease in LPL protein production than D-factor. These results provide in vitro evidence that physiologically attainable concentrations of D-factor can produce catabolic alterations in fatty acid metabolism and suggest that D-factor inhibits LPL activity primarily through effects on post-transcriptional processing. D-factor, alone and in combination with TNF, may contribute to the manifestations of cachexia.

References (47)

HN Langstein et al.
Mechanisms of Cancer Cachexia
Hematol Oncol Clin North Am
(1991)
A Oliff
The role of tumor necrosis factor (cachectin) in cachexia
Cell
(1988)
SR Price et al.
Regulation of lipoprotein lipase synthesis by recombinant tumor necrosis factor—the primary regulatory role of the hormone in 3T3-L1 adipocytes
Arch Biochem Biophys
(1986)
H Semb et al.
Multiple effects of tumor necrosis factor on lipoprotein lipase in vivo
J Biol Chem
(1987)
DJ Hilton
LIF: lots of interesting functions
Trends in biochemical sciences
(1992)
D Metcalf et al.
Effects of injected leukemia inhibitory factor on hematopoietic and other tissues in mice
Blood
(1990)
M Mori et al.
Purification of a lipoproetin lipase-inhibiting protein produced by a melanoma cell line associated with cancer cachexia
Biochem Biophys Res Comm
(1989)
H-J Gruss et al.
Involvement of nuclear factor-kB in induction of the interleukin-6 gene by leukemia inhibitory factor
Blood
(1992)
T Olivecrona et al.
Synthesis and secretion of lipoprotein lipase in 3T3-L1 adipocytes
J Biol Chem
(1987)
H Masuno et al.
Synthesis of inactive nonsecretable high mannose-type lipoprotein lipase by cultured brown adipocytes of combined lipase-deficient $cld cld$ mice
J Biol Chem
(1990)

H Masuno et al.

Retention of glucose by N-linked oligosaccharide chains impedes expression of lipoprotein lipase activity: effect of castanospermine

J Lipid Res

(1992)

RO Scow et al.

Transport of fatty acids and monoacylglycerols in white and brown adipose tissues

Brain Res Bull

(1991)

CS Rubin et al.

Development of hormone receptors and hormonal responsiveness in vitro

J Biol Chem

(1978)

P Chomczynski et al.

Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction

Anal Biochem

(1987)

P Nilsson-Ehle et al.

A stable, radioactive substrate emulsion for assay of lipoprotein lipase

J Lipid Res

(1976)

B Beutler

Cachexia: a fundamental mechanism

Nutr Rev

(1988)

PH Pekala et al.

Model for cachexia in chronic disease: secretory products of endotoxin-stimulated macrophages induce a catabolic state in 3T3-L1 adipocytes

Trans Assoc Am Physicians

(1984)

B Beutler et al.

Cachectin and tumour necrosis factor as two sides of the biological coin

Nature

(1986)

B Beutler et al.

Cachectin, cachexia, and shock

Ann Rev Med

(1988)

B Beutler et al.

Purification of cachectin, a lipoprotein lipase suppressive hormone secreted by endotoxin-induced RAW 264.7 cells

J Exp Med

(1985)

KR Feingold et al.

Effect of tumor necrosis factor (TNF) on lipid metabolism in the diabetic rat

J Clin Invest

(1989)

D Grunfeld et al.

Persistence of the hypertriglyceridemic effect of tumor necrosis factor despite development of tachyphylaxis to its anorectic-cachectic effects in rats

Cancer Res

(1989)

D Metcalf

The Leukemia inhibitory factor (LIF)

Int J Cell Cloning

(1991)

Cited by (67)

Epigenetic regulation of lipoprotein lipase gene via BRD4, which is potentially associated with adipocyte differentiation and insulin resistance
2019, European Journal of Pharmacology
Citation Excerpt :
In addition, the plasma LPL activity in adipose tissue is reduced by the development of insulin resistance (de Vries et al., 2003). Furthermore, TNF-α downregulates the expression of Lpl and its activity in adipocytes (Berg et al., 1994; Makoveichuk et al., 2017; Morin et al., 1995). Therefore, our study at least partially clarifies a molecular or epigenetic mechanism behind BRD4-associated insulin resistance.
Lipoprotein lipase (LPL) is the rate-controlling enzyme for the accumulation of triacylglycerol into adipocytes, which acts by digesting it into glycerol and fatty acids. In this study, we found that treatment with (+)-JQ1, an inhibitor of the bromodomain and extra-terminal (BET) family proteins, for 4 days from the end of stimulation to induce adipocyte differentiation reduced binding of BRD4, a BET family member, within the gene body of Lpl. This eventually downregulated the expression of Lpl in 3T3-L1 adipocytes. Longer treatment for 8 days reduced the acetylation of histones H3 and H4 within the gene body of Lpl and subsequent Lpl expression. Lpl expression in mesenteric adipose tissues was lower in Brd4^+/− heterozygous mice at 14 days after birth than in wild-type mice at the same age. Furthermore, treatment with an inducer of insulin resistance, tumor necrosis factor-α, reduced BRD4 binding and histone acetylation in the gene body of Lpl and its expression. These results indicate that transcriptional elongation of Lpl controlled by BRD4 may be associated with adipocyte differentiation, and that its suppression is potentially associated with insulin resistance of adipocytes.
Anterior pituitary influence on adipokine expression and secretion by porcine adipocytes
2016, Animal
Nutritional stressors may cause negative effects on animal health and growth and lead to significant economic impact. Adipose tissue is an endocrine organ producing, mediators and hormones, called adipokines. They play a dynamic role in body homeostasis and in the regulation of energy expenditure, interacting with feeding behavior, hormones and growth factors. This in vitro study aimed to investigate how nutritional conditions and growth hormone (GH) can influence nitric oxide (NO) production and the expression and secretion of three important adipokines, that is leptin, interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α), by swine adipocytes. In our experimental model, mesenchymal stem cells from omental adipose tissue were induced to adipogenic differentiation. After differentiation, adipocytes were incubated for 24 h (T0) with DMEM/Ham’s F12 (group A) or DMEM/Ham’s F12 salts (group B), a DMEM/Ham’s F12 formulation deprived of nutritional components. Primary adipocyte cells were also co-cultured for 4 h (T+4) or 12 h (T+12) with or without anterior pituitary slices. To stimulate GH secretion by pituitary cells, growth hormone releasing hormone at 10⁻⁸ M was added at the start of the incubation times (4 or 12 h). At T0, T+4 and T+12, NO production, leptin, IL-6 and TNF-α expression and secretion were measured. NO increased (P<0.05) up to twofold in restricted culture conditions. Deprived medium and coincubation with anterior pituitary positively influenced leptin secretion and expression. TNF-α was expressed and secreted only in deprived culture condition groups (B, B1 and B2). Nutrients availability and pituitary co-culture did not affect IL-6 expression and secretion. Our study shows an endocrine function for porcine adipocytes. In our model, adipocytes readily responded to nutritional inputs by secretion of molecules affecting energy balance. This secretion capacity was modulated by GH. Improving our knowledge of the role of adipocyte in the endocrine system, may lead to a more complete understanding of regulating energy balance in swine.
A key role for leukemia inhibitory factor in C26 cancer cachexia
2015, Journal of Biological Chemistry
Citation Excerpt :
Previously, LIF has been suggested as a candidate cachexia factor requiring further study (31). LIF is a known inhibitor of lipoprotein lipase, an enzyme that affects adipose tissue and whose inhibition results in the loss of body fat (32). Circulating LIF was found to be correlated with cachexia when expressed by melanoma (31), and when purified LIF is injected in normal mice, body fat is lost within 2 weeks (33).
Cachexia is an exacerbating event in many types of cancer that is strongly associated with a poor prognosis. We have identified cytokine, signaling, and transcription factors that are required for cachexia in the mouse C26 colon carcinoma model of cancer. C2C12 myotubes treated with conditioned medium from C26 cancer cells induced atrophy and activated a STAT-dependent reporter gene but not reporter genes dependent on SMAD, FOXO, C/EBP, NF-κB, or AP-1. Of the gp130 family members IL-11, IL-6, oncostatin M (OSM), and leukemia inhibitory factor (LIF), only OSM and LIF were sufficient to activate the STAT reporter in myotubes. LIF was elevated in C26 conditioned medium (CM), but IL-6, OSM, TNFα, and myostatin were not. A LIF-blocking antibody abolished C26 CM-induced STAT reporter activation, STAT3 phosphorylation, and myotube atrophy but blocking antibodies to IL-6 or OSM did not. JAK2 inhibitors also blocked C26 CM-induced STAT reporter activation, STAT3 phosphorylation, and atrophy in myotubes. LIF at levels found in the C26 CM was sufficient for STAT reporter activation and atrophy in myotubes. In vivo, an increase in serum LIF preceded the increase in IL-6 in mice with C26 tumors. Overexpression of a dominant negative Stat3Cβ-EGFP gene in myotubes and in mouse muscle blocked the atrophy caused by C26 CM or C26 tumors, respectively. Taken together, these data support an important role of LIF-JAK2-STAT3 in C26 cachexia and point to a therapeutic approach for at least some types of cancer cachexia.
Inflammation and insulin/IGF-1 resistance as the possible link between obesity and neurodegeneration
2014, Journal of Neuroimmunology
Citation Excerpt :
TNFα impacts immune responses via activation of macrophages and neutrophils, induction of apoptosis, regulation of lipid metabolism and insulin signaling within adipose tissue (Simons et al., 2007). Additionally, TNFα suppresses the release of the anti-inflammatory molecule adiponectin, while inducing the secretion of the pro-inflammatory cytokine IL-6 from adipose tissue (Berg et al., 1994; P.A. Kern et al., 2001; Simons et al., 2007). IL-6 is a powerful pro-inflammatory cytokine, which regulates B and T cell functions, induces hematopoiesis, stimulates platelet production, immunoglobulin synthesis and acute-phase response (Kopf et al., 1994; Yamashita et al., 1994; Biffl et al., 1996).
Obesity is a growing epidemic that contributes to several brain disorders including Alzheimer's, Parkinson's, and Huntington's diseases. Obesity could promote these diseases through several different mechanisms. Here we review evidence supporting the involvement of two recently recognized factors linking obesity with neurodegeneration: the induction of pro-inflammatory cytokines and onset of insulin and insulin-like growth factor 1 (IGF-1) resistance. Excess peripheral pro-inflammatory mediators, some of which can cross the blood brain barrier, may trigger neuroinflammation, which subsequently exacerbates neurodegeneration. Insulin and IGF-1 resistance leads to weakening of neuroprotective signaling by these molecules and can contribute to onset of neurodegenerative diseases.
The role of triglyceride lipases in cancer associated cachexia
2013, Trends in Molecular Medicine
Cancer associated cachexia (CAC) is a complex multiorgan syndrome frequently associated with various forms of cancer. Affected patients suffer from a dramatic loss of skeletal muscle and adipose tissue. Most cases are accompanied by anorexia, and nutritional supplements are not sufficient to stop or reverse its course. CAC impairs many forms of therapeutic interventions and accounts for 15–20% of all deaths of cancer patients. Recently, several studies have recognized the importance of lipid metabolism and triglyceride hydrolysis as a major metabolic pathway involved in the initiation and/or progression of CAC. In this review, we explore the contributions of the triglyceride lipases to CAC and discuss various factors modulating lipase activity.
Stimulation of sub-sonic vibration promotes the differentiation of adipose tissue-derived mesenchymal stem cells into neural cells
2012, Life Sciences
Citation Excerpt :
Transforming growth factor-beta1 (TGF-β1), potent regulator of mesenchymal cell development, is the cytokine to inhibit adipogenesis and acts to maintain preadipocytes in an undifferentiated state in vitro and in vivo studies (Choy et al., 2000; Clouthier et al., 1997). In most relevant studies, proteins secreted by adipose tissues are inflammatory cytokines such as Interleukin-1β and tumor necrosis factor-α (TNF-α) that are inhibitors of preadipocyte differentiation in vitro (Berg et al., 1994; MacDouglad and Mandrup, 2002). Especially, TNF-α is potent inhibitor of adipocyte differentiation and secreted or membrane-bound TNF-α acts through TNF-α receptor 1 to inhibit adipogenesis, in part through sustained activation of the ERK pathway (Xu et al., 1999).
Adipose tissue-derived stem cells (AT-MSCs) have been proposed as a new source for nervous tissue damage due to their capacity of neural differentiation potential including neurons, oligodendrocytes and astrocytes. Recently, many studies have demonstrated that sub-sonic vibration (SSV) is an effective cell differentiation method but there have been no studies on the effect of SSV about AT-MSC differentiation into neural-like cells in vitro. Therefore, we examined the effect of SSV on AT-MSCs to investigate the differentiation potential of neural-like cells.
We assessed the changes in AT-MSCs by SSV during 4 days at 10, 20, 30 and 40 Hz (1.0 V). After stimulation, they were analyzed by RT-PCR, Western blot and immunohistological analysis using neural cell type-specific genes and antibodies. Further, to confirm the neural differentiation, we investigated adipogenic genes for RT-PCR analysis. For a mechanism study, we analyzed activation levels in time course of ERK phosphorylation after SSV.
After 4-day SSV exposure, we observed morphological changes of AT-MSCs. Further, SSV induced gene/protein levels of neural markers while inhibiting adipogenesis and they were mainly upregulated at 30 Hz. In addition, phosphorylated ERK level was increased in a time-dependent manner upon 30 Hz SSV for 6 h.
These results demonstrated that SSV affects AT-MSCs differentiation potential and 30 Hz SSV affected neural differentiation on AT-MSCs.

View all citing articles on Scopus

View full text

Original contributionCharacterization of differentiation factor/leukaemia inhibitory factor effect of lipoprotein lipase activity and mRNA in 3T3-L1 adipocytes

Abstract

Hematol Oncol Clin North Am

Cell

Arch Biochem Biophys

J Biol Chem

Trends in biochemical sciences

Blood

Biochem Biophys Res Comm

Blood

J Biol Chem

J Biol Chem

J Lipid Res

Brain Res Bull

J Biol Chem

Anal Biochem

J Lipid Res

Cachexia: a fundamental mechanism

Nutr Rev

Model for cachexia in chronic disease: secretory products of endotoxin-stimulated macrophages induce a catabolic state in 3T3-L1 adipocytes

Trans Assoc Am Physicians

Cachectin and tumour necrosis factor as two sides of the biological coin

Nature

Cachectin, cachexia, and shock

Ann Rev Med

Purification of cachectin, a lipoprotein lipase suppressive hormone secreted by endotoxin-induced RAW 264.7 cells

J Exp Med

Effect of tumor necrosis factor (TNF) on lipid metabolism in the diabetic rat

J Clin Invest

Persistence of the hypertriglyceridemic effect of tumor necrosis factor despite development of tachyphylaxis to its anorectic-cachectic effects in rats

Cancer Res

The Leukemia inhibitory factor (LIF)

Int J Cell Cloning

Original contribution
Characterization of differentiation factor/leukaemia inhibitory factor effect of lipoprotein lipase activity and mRNA in 3T3-L1 adipocytes